Clinical Research Directory

A Long-term Follow up Study of EXG102-031 in Participants With wAMD

Sponsor: Guangzhou Jiayin Biotech Ltd

Summary

This is a long-term, safety and efficacy follow-up study of patients in the EXG102-031-111 gene therapy clinical trial for wAMD. Patients will complete visits from the parent study, and then into this long-term follow-up study for continuous safety monitoring for up to 5 years.

Official title: A Long-term Follow-up Study to Evaluate the Injection of EXG102-031 Ophthalmic Injection in Participants With Wet Age-related Macular Degeneration (wAMD).

Key Details

Conditions

Interventions

Locations (1)